Richard Francis, Teva CEO
Teva plans sale of API unit amid 'pivot to growth'
Teva’s drug ingredients unit is apparently not making the pivot.
Less than a year into its “pivot to growth” strategy, Teva has announced plans to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
